Scientific Digital Imaging Plc PXi Touch being used at University of Cambridge
May 01 2014 - 2:01AM
RNS Non-Regulatory
TIDMSDI
Scientific Digital Imaging Plc
01 May 2014
Scientific Digital Imaging Plc
PXi Touch being used in a new application by the University of
Cambridge
Cambridge, UK: Scientific Digital Imaging (AIM: SDI, "SDI" or
the "Company"), the AIM quoted group focused on the application of
digital imaging technology to the needs of the scientific community
confirms that its PXi Touch imaging system is being used in a new
application by scientists at the UK's University of Cambridge to
visualise multiplex fluorescent and chemiluminescent labelled
proteins on the same Western blots. This is contributing to rapidly
providing researchers there with more accurate and reproducible
results.
Researchers in the Department of Pharmacology at the University
of Cambridge are using a PXi Touch multi-application imager to
analyse proteins on Western blots stained with chemiluminescent and
multiplex fluorescent dyes.
Dr Emily Taylor, Laboratory Manager in the Department of
Pharmacology commented: "We want to perform multiplex fluorescent
Westerns because we can use the same blot to probe for different
proteins as we're looking at proteins ranging 30 kDa to 260 kDa and
it is quicker and easier to use just one blot rather than looking
at multiple blots for each protein. For this application, we
assessed the PXi Touch alongside a laser based scanning system and
chose the PXi Touch because the touch screen software is easy to
use and the camera is very sensitive."
Dr Taylor continued: "Since we began using the PXi Touch system,
we have discovered that the imaging capability is so good we can
interchangeably use multiplex fluorescence and chemi dyes. We now
use chemi to detect proteins expressed by our house keeping genes
and fluorescence for the proteins of interest. We do this as
fluorescence has a better linear range but chemi is more sensitive
so we mix and match the two detection methods on the same blot and
this is helping us to obtain greater accuracy and reproducibility
of results."
Laura Sullivan, Divisional Manager of SDI's subsidiary Syngene
stated: "We are excited to hear that our latest imaging technology
is being utilised at such a prestigious institute for this novel
mixed imaging application. Their research shows scientists that
using a PXi Touch means they can work smarter to obtain optimum
results, time after time from their Western blots."
- Ends -
For Further Information Contact:
Scientific Digital Imaging:
Mike Creedon, Chief Executive of SDI - 01223 727144
finnCap
Ed Frisby / Ben Thompson, corporate finance - 020 7220 0500
Simon Starr / Mia Gardner, corporate broking
JW Communications
Julia Wilson, Investor & Public Relations - 0781 8430877
Note to Editors
About Scientific Digital Imaging plc
Scientific Digital Imaging plc (SDI) is focused on the
application of digital imaging technology to the needs of the
scientific and technology community. Its principal subsidiary is
Synoptics Limited, which designs and manufactures special-purpose
instruments for use mainly in the life sciences, supplying
customers in the academic, research and health sectors. Within
Synoptics, the recently formed Synoptics Health division has
launched the Synoptics Health ProReveal system. This patented
system offers a highly sensitive fluorescence-based test to detect
dirty surgical instruments in hospitals and aims to reduce
incidences of cross contamination of patients. In addition, under
the Atik brand, SDI designs and manufactures high-sensitivity
cameras for both astronomical and life science applications.
www.scientificdigitalimaging.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
NRAFMGFDNGKGDZM
Sdi (LSE:SDI)
Historical Stock Chart
From Jun 2024 to Jul 2024
Sdi (LSE:SDI)
Historical Stock Chart
From Jul 2023 to Jul 2024